This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Keith Abe
Introduction
Keith Abe is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for thrombosis. His innovative work has led to the creation of a patent that addresses critical medical needs.
Latest Patents
Keith Abe holds a patent for "Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor." This patent describes unit doses of factor Xa inhibitor compounds and methods for using these compounds to inhibit blood coagulation in human patients. Notably, the unit dose required to inhibit coagulation in primates is lower than that required in other animal models, such as rodents. The patent also includes in vitro assays that are useful in predicting in vivo antithrombotic activity in humans.
Career Highlights
Keith Abe is associated with Millennium Pharmaceuticals Limited, where he has been instrumental in advancing pharmaceutical innovations. His work has focused on developing effective treatments that can significantly improve patient outcomes in the area of blood coagulation.
Collaborations
Throughout his career, Keith has collaborated with notable colleagues, including Uma Sinha and Stanley J. Hollenbach. These partnerships have contributed to the success of his projects and the advancement of medical research.
Conclusion
Keith Abe's contributions to the field of pharmaceuticals, particularly through his patent on factor Xa inhibitors, highlight his role as an innovative inventor. His work continues to impact the medical community positively, paving the way for advancements in thrombosis treatment.